Compare SHASUN PHARMA with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA FDC LTD. SHASUN PHARMA/
FDC LTD.
 
P/E (TTM) x 123.9 18.0 689.1% View Chart
P/BV x 8.5 2.7 314.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHASUN PHARMA   FDC LTD.
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
FDC LTD.
Mar-18
SHASUN PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs94319 29.5%   
Low Rs46164 27.8%   
Sales per share (Unadj.) Rs214.261.6 347.4%  
Earnings per share (Unadj.) Rs5.39.9 53.6%  
Cash flow per share (Unadj.) Rs15.812.0 132.2%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.373.2 72.9%  
Shares outstanding (eoy) m56.62174.40 32.5%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.33.9 8.3%   
Avg P/E ratio x13.124.3 54.0%  
P/CF ratio (eoy) x4.420.2 21.9%  
Price / Book Value ratio x1.33.3 39.7%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,95842,118 9.4%   
No. of employees `000NA5.5 0.0%   
Total wages/salary Rs m2,1642,167 99.9%   
Avg. sales/employee Rs ThNM1,943.7-  
Avg. wages/employee Rs ThNM391.7-  
Avg. net profit/employee Rs ThNM313.7-  
INCOME DATA
Net Sales Rs m12,12710,751 112.8%  
Other income Rs m229510 45.0%   
Total revenues Rs m12,35611,260 109.7%   
Gross profit Rs m1,0092,267 44.5%  
Depreciation Rs m594351 168.9%   
Interest Rs m41514 2,965.0%   
Profit before tax Rs m2302,411 9.5%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73671 -10.8%   
Profit after tax Rs m3021,735 17.4%  
Gross profit margin %8.321.1 39.5%  
Effective tax rate %-31.727.8 -113.7%   
Net profit margin %2.516.1 15.4%  
BALANCE SHEET DATA
Current assets Rs m6,8847,213 95.5%   
Current liabilities Rs m8,4562,104 402.0%   
Net working cap to sales %-13.047.5 -27.3%  
Current ratio x0.83.4 23.7%  
Inventory Days Days6254 113.1%  
Debtors Days Days10828 387.9%  
Net fixed assets Rs m4,9706,865 72.4%   
Share capital Rs m113175 64.7%   
"Free" reserves Rs m2,87512,586 22.8%   
Net worth Rs m3,02012,761 23.7%   
Long term debt Rs m1,8176 30,290.0%   
Total assets Rs m13,34715,041 88.7%  
Interest coverage x1.6173.2 0.9%   
Debt to equity ratio x0.60 127,982.8%  
Sales to assets ratio x0.90.7 127.1%   
Return on assets %5.411.6 46.2%  
Return on equity %10.013.6 73.6%  
Return on capital %13.319.0 70.3%  
Exports to sales %46.412.3 375.6%   
Imports to sales %14.20-   
Exports (fob) Rs m5,6221,327 423.7%   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,8431,889 309.3%   
Fx outflow Rs m2,1730-   
Net fx Rs m3,6691,889 194.3%   
CASH FLOW
From Operations Rs m3981,498 26.5%  
From Investments Rs m-1,635201 -813.0%  
From Financial Activity Rs m1,309-1,694 -77.2%  
Net Cashflow Rs m7110 691.3%  

Share Holding

Indian Promoters % 39.2 68.9 56.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 4.7 76.6%  
FIIs % 17.6 7.5 234.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 19.0 208.4%  
Shareholders   20,750 23,730 87.4%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   VENUS REMEDIES  PROCTER & GAMBLE HEALTH  SANOFI INDIA  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 186 Points Higher; Energy and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day on a positive note.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS